References
- RiksmanJSWilliamsonODWalkerBFDelineating inflammatory and mechanical sub-types of low back pain: a pilot survey of fifty low back pain patients in a chiropractic settingChiropr Man Ther20111915
- CalinAKayeBSternbergMAntellBChanMThe prevalence and nature of back pain in an industrial complex: a questionnaire and radiographic and HLA analysisSpine1980522012056446164
- SidiropoulosPHatemiGSongI-HEvidence-based recommendations for the management of ankylosing spondylitis: systematic literature search of the 3E Initiative in Rheumatology involving a broad panel of experts and practising rheumatologistsRheumatology200847335536118276738
- LeeYCEffect and treatment of chronic pain in inflammatory arthritisCurr Rheumatol Rep201315130023292816
- SieperJvan der HeijdeDLandeweRNew criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS)Ann Rheum Dis200968678478819147614
- WalkerBFWilliamsonODMechanical or inflammatory low back pain. What are the potential signs and symptoms?Man Ther200914331432018555728
- ChouRPharmacological management of low back painDrugs201070438740220205483
- LastARHulbertKChronic low back pain: evaluation and managementAm Fam Physician200979121067107419530637
- PeretzAInflammatory low back painRev Med Brux2007284290293 French17958023
- SchlossbauerTPanteleonABecker-GaabCInflammatory spine disease as a cause of back painRadiologe2006466468479 German16786384
- BraunJZochlingJBaraliakosXEfficacy of sulfasalazine in patients with inflammatory back pain due to undifferentiated spondyloarthritis and early ankylosing spondylitis: a multicentre randomised controlled trialAnn Rheum Dis20066591147115316606646
- DougadosMvam der LindenSLeirisalo-RepoMSulfasalazine in the treatment of spondylarthropathy. A randomized, multicenter, double-blind, placebo-controlled studyArthritis Rheum19953856186277748217
- CleggDORedaDJAbdellatifMComparison of sulfasalazine and placebo for the treatment of axial and peripheral articular manifestations of the seronegative spondylarthropathies: a Department of Veterans Affairs cooperative studyArthritis Rheum199942112325232910555027
- ChenJLiuCSulfasalazine for ankylosing spondylitisCochrane Database Syst Rev20052CD00480015846731
- MachadoPvan der HeijdeDHow to measure disease activity in axial spondyloarthritis?Curr Opin Rheumatol201123433934521519269
- van der LindenSvan der HeijdeDAnkylosing spondylitis: clinical featuresRheum Dis Clin North Am19982446636769891705
- DougadosMDijkmansBKhanMMaksymowychWVan der LindenSBrandtJConventional treatments for ankylosing spondylitisAnn Rheum Dis200261Suppl 3iii40iii5012381510
- KeithMPOverview of drug therapy for spondyloarthritisRheumatol Curr Res20133119
- ChenJLiuCIs sulfasalazine effective in ankylosing spondylitis? A systematic review of randomized controlled trialsJ Rheumatol200633472273116583475
- Benitez-Del-CastilloJMGarcia-SanchezJIradierTBañaresASulfasalazine in the prevention of anterior uveitis associated with ankylosing spondylitisEye (Lond)200014Pt 3A34034311026996
- BrentLHKalagateRAnkylosing spondylitis and undifferentiated spondyloarthropathy Available from: emedicine.medscape.com/article/332945-overviewAccessed November 3, 2009
- NissiläMLehtinenKLeirisalo-RepoMLuukkainenRMutruOYli-KerttulaUSulfasalazine in the treatment of ankylosing spondylitisArthritis Rheum1988319111111162901839